BAOMINH VINH: Open Payments
NPI 1578707303 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,186 in 117 payments from 21 companies in 2025. Trend: 2023 $6,989 · 2024 $4,257 · 2025 $5,186
Food & beverage: $3,878Travel & lodging: $1,308
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 19 | $1,964 |
| Saluda Medical Americas, Inc. | 18 | $682 |
| ABBVIE INC. | 19 | $407 |
| Abbott Laboratories | 6 | $407 |
| Globus Medical, Inc. | 4 | $272 |
| TerSera Therapeutics LLC | 6 | $242 |
| Boston Scientific Corporation | 4 | $239 |
| MML US, Inc. | 10 | $210 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $127 |
| Nalu Medical, Inc. | 5 | $98 |
Products named: SYNCHROMEDII, Evoke, Senza, Prialt, ETERNA, ReActiv8, BOTOX, QULIPTA.
Industry payments across TX — which companies pay providers there.
